Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa

Table 4

Mortality and survival in relation to oral HIV-KS.

	Males	Females	Total
Mortality
Number of patients who died	11 (85%)	10 (66%)	21 (75%)
Average time of death from oral HIV-KS diagnosis	15 weeks	12.1 weeks	13.6 weeks
Average CD4+ T cell count (cells/mm^3) at oral HIV-KS diagnosis	75	54	64
Survival
Number of patients who survived	2 (15%)	5 (33%)	7 (25%)
Average follow-up time	76 weeks	106 weeks	91 weeks
Average CD4+ T cell count (cells/mm^3) at oral HIV-KS diagnosis	258	129	166